estriol has been researched along with Edema, Fetal in 6 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydropic Down syndrome pregnancies had significantly lower MSAFP and estriol concentrations, while hCG levels were higher." | 3.71 | Extreme second-trimester serum analyte values in down syndrome pregnancies with hydrops fetalis. ( Benn, PA; Egan, JF; Ingardia, CJ, 2002) |
| "The combination of maternal serum alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin levels and maternal age has been used to increase the sensitivity of screening for fetal Down syndrome and trisomy 18 in early-second-trimester pregnancies." | 3.68 | Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome. ( Blitzer, MG; Canick, JA; Saller, DN; Schwartz, S, 1992) |
| "Estriol was significantly lower when a fetal cystic hygroma was detected on ultrasound compared to those with no cystic hygroma (0." | 1.31 | Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21. ( El-Bastawissi, A; Luthhardt, F; Luthy, DA; Nyberg, DA; Souter, VL; Zebelman, A, 2002) |
| "These data for Turner syndrome are similar to those for human chorionic gonadotropin (hCG)." | 1.30 | Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops. ( Canick, JA; French, CA; Lambert-Messerlian, GM; Peterson, CJ; Saller, DN; Tumber, MB, 1998) |
| "Gross malformations and hydrops fetalis were detected in 15 and 5 fetuses, respectively." | 1.29 | An artificial intelligent diagnostic system with neural networks to determine genetical disorders and fetal health by using maternal serum markers. ( Balci, S; Beksaç, MS; Cakar, AN; Durak, B; Karakaş, U; Laleli, Y; Ozkan, O, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benn, PA | 1 |
| Egan, JF | 1 |
| Ingardia, CJ | 1 |
| Beksaç, MS | 1 |
| Durak, B | 1 |
| Ozkan, O | 1 |
| Cakar, AN | 1 |
| Balci, S | 1 |
| Karakaş, U | 1 |
| Laleli, Y | 1 |
| Saller, DN | 3 |
| Canick, JA | 3 |
| Oyer, CE | 1 |
| Lambert-Messerlian, GM | 1 |
| Tumber, MB | 1 |
| French, CA | 1 |
| Peterson, CJ | 1 |
| Souter, VL | 1 |
| Nyberg, DA | 1 |
| El-Bastawissi, A | 1 |
| Zebelman, A | 1 |
| Luthhardt, F | 1 |
| Luthy, DA | 1 |
| Schwartz, S | 1 |
| Blitzer, MG | 1 |
6 other studies available for estriol and Edema, Fetal
| Article | Year |
|---|---|
Extreme second-trimester serum analyte values in down syndrome pregnancies with hydrops fetalis.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Humans; Hydrops F | 2002 |
An artificial intelligent diagnostic system with neural networks to determine genetical disorders and fetal health by using maternal serum markers.
Topics: Adolescent; Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosome Aberrations; C | 1995 |
The detection of non-immune hydrops through second-trimester maternal serum screening.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Fluorescent Antib | 1996 |
Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.
Topics: alpha-Fetoproteins; Blood Preservation; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Cryopre | 1998 |
Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Cohort Studies; Down Syndrome; Estriol; Female; Heart De | 2002 |
Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Fetal Diseas | 1992 |